After a successful meeting in December 2023 to launch the PARASOL initiative, the group reconvened this year on June 8th and 9th in Reykjavik, Iceland, for an interim assessment of the effort. Read more about the meeting in the August issue of Kidney News.
From its inception, the PARASOL initiative set an ambitious timeline of 11 months. The gathering of all participants at this interim meeting confirmed that the project is on schedule and moving full steam ahead and in the right direction. The next milestone is a public scientific workshop cosponsored by the US Food and Drug Administration to be held October 7–8, 2024, in Bethesda, MD. Additional presentations will be offered for the larger community at ASN Kidney Week later that month in San Diego, CA.
Dr. Howard Trachtman
I attended Haverford College and University of Pennsylvania School of Medicine. I completed my residency training at Tufts-New England Medical Center and Bronx Municipal Hospital Center and my fellowship in Pediatric Nephrology at Albert Einstein College of Medicine. I was Professor of Clinical Pediatrics and chief of the Division of Pediatric Nephrology at NYU Grossman School of Medicine and NYU Langone Health from December 2011 until June 2021. I have been the PI of NIDDK and industry sponsored clinical trials in glomerular disease and am a Co-Investigator in the NEPTUNE and CureGN observational cohort studies. I am the Co-PI on ongoing studies evaluating the impact of environmental chemical exposures on kidney development and disease progression in children and adults with CKD. I am on the Medical Advisory Board of the Alport Syndrome Foundation, on the editorial board of Kidney360, Glomerular Diseases, and Pediatric Nephrology and on the Board of Directors of the Kidney Health Initiative (KHI).
COMMENTS